Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells.

Abstract

Tamibarotene (TM411) is a synthetic retinoic acid receptor-alpha/-beta selective retinoid that is chemically more stable than all-trans retinoic acid. This study was designed to evaluate the activity of TM411 in multiple myeloma (MM) and the effects of TM411 combined with a glucocorticoid (GC). In vitro, five human myeloma cells were treated with TM411… (More)

Topics

  • Presentations referencing similar topics